SE418247B - Sett att framstella kroppar med reglerad frigoring av en aktiv komponent - Google Patents

Sett att framstella kroppar med reglerad frigoring av en aktiv komponent

Info

Publication number
SE418247B
SE418247B SE7512883A SE7512883A SE418247B SE 418247 B SE418247 B SE 418247B SE 7512883 A SE7512883 A SE 7512883A SE 7512883 A SE7512883 A SE 7512883A SE 418247 B SE418247 B SE 418247B
Authority
SE
Sweden
Prior art keywords
active component
regulated release
make bodies
bodies
make
Prior art date
Application number
SE7512883A
Other languages
English (en)
Swedish (sv)
Other versions
SE7512883L (sv
Inventor
C B Bogentoft
C H Appelgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE7512883A priority Critical patent/SE418247B/xx
Priority to ZA766669A priority patent/ZA766669B/xx
Priority to NO763807A priority patent/NO144763C/no
Priority to DE19762651176 priority patent/DE2651176A1/de
Priority to FI763257A priority patent/FI62462C/fi
Priority to DK513476A priority patent/DK146213C/da
Priority to NZ182621A priority patent/NZ182621A/xx
Priority to AU19617/76A priority patent/AU508266B2/en
Priority to DD7600195783A priority patent/DD128170A5/xx
Priority to IE2516/76A priority patent/IE44353B1/en
Priority to AT850576A priority patent/AT354636B/de
Priority to CS767375A priority patent/CS207374B2/cs
Priority to FR7634515A priority patent/FR2331375A1/fr
Priority to NLAANVRAGE7612728,A priority patent/NL187259C/xx
Priority to GB47730/76A priority patent/GB1560841A/en
Priority to CA265,748A priority patent/CA1075031A/en
Priority to LU76215A priority patent/LU76215A1/xx
Priority to BE172413A priority patent/BE848406A/xx
Priority to SU762420506A priority patent/SU1326180A3/ru
Priority to JP51137414A priority patent/JPS5919526B2/ja
Priority to HU76HE724A priority patent/HU173461B/hu
Publication of SE7512883L publication Critical patent/SE7512883L/
Priority to US06/013,124 priority patent/US4289795A/en
Priority to US06/200,998 priority patent/US4341759A/en
Publication of SE418247B publication Critical patent/SE418247B/xx
Priority to HK146/83A priority patent/HK14683A/xx
Priority to MY19/84A priority patent/MY8400019A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
SE7512883A 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent SE418247B (sv)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE7512883A SE418247B (sv) 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
ZA766669A ZA766669B (en) 1975-11-17 1976-11-08 A method for preparing preparations having controlled release of an active component
NO763807A NO144763C (no) 1975-11-17 1976-11-09 Fremgangsmaate for fremstilling av preparater som har kontrollert frigivning av en aktiv forbindelse
DE19762651176 DE2651176A1 (de) 1975-11-17 1976-11-10 Mittel mit geregelter wirkstoffabgabe und verfahren zu dessen herstellung
FI763257A FI62462C (fi) 1975-11-17 1976-11-12 Foerfarande foer framstaellning av preparat som kontrollerat avger en aktiv komponent
DK513476A DK146213C (da) 1975-11-17 1976-11-15 Fremgangsmaade til fremstilling af smaalegemer med kontrolleret afgivelse af en aktiv komponent
NZ182621A NZ182621A (en) 1975-11-17 1976-11-15 Controlled release particulate bodies
AU19617/76A AU508266B2 (en) 1975-11-17 1976-11-15 Controlled release preparations
DD7600195783A DD128170A5 (de) 1975-11-17 1976-11-15 Verfahren zur herstellung von praeparaten mit geregelter wirkstoffabgabe
NLAANVRAGE7612728,A NL187259C (nl) 1975-11-17 1976-11-16 Werkwijze voor het bereiden van preparaten, die een werkzaam bestanddeel met een geregelde snelheid afgeven.
AT850576A AT354636B (de) 1975-11-17 1976-11-16 Verfahren zur herstellung eines praeparates mit gesteuerter abgabe einer aktiven komponente
CS767375A CS207374B2 (en) 1975-11-17 1976-11-16 Method of making the preparations liberating at least one active component following the desintegration
FR7634515A FR2331375A1 (fr) 1975-11-17 1976-11-16 Procede pour l'obtention de preparations avec liberation reglee d'un principe actif
IE2516/76A IE44353B1 (en) 1975-11-17 1976-11-16 Preparations having controlled release of an active component
GB47730/76A GB1560841A (en) 1975-11-17 1976-11-16 Preparations having controlled release of an active component
CA265,748A CA1075031A (en) 1975-11-17 1976-11-16 Controlled rate of release preparations
SU762420506A SU1326180A3 (ru) 1975-11-17 1976-11-17 Способ получени препарата продленного действи
BE172413A BE848406A (fr) 1975-11-17 1976-11-17 Procede pour la production de preparations aptes a liberer de maniere controlee un compose actif,
LU76215A LU76215A1 (xx) 1975-11-17 1976-11-17
JP51137414A JPS5919526B2 (ja) 1975-11-17 1976-11-17 制御された活性成分放出速度を有する調製物の製法
HU76HE724A HU173461B (hu) 1975-11-17 1976-11-17 Sposob poluchenija preparatov vypuskajuhhikh aktivnoe vehhestvo regulirovannym putem
US06/013,124 US4289795A (en) 1975-11-17 1979-02-21 Method for preparing preparations having controlled release of an active component
US06/200,998 US4341759A (en) 1975-11-17 1980-10-27 Granule having controlled release properties
HK146/83A HK14683A (en) 1975-11-17 1983-05-05 Preparations having controlled release of an active component
MY19/84A MY8400019A (en) 1975-11-17 1984-12-30 Preparations having controlled release of an active component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7512883A SE418247B (sv) 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent

Publications (2)

Publication Number Publication Date
SE7512883L SE7512883L (sv) 1977-05-18
SE418247B true SE418247B (sv) 1981-05-18

Family

ID=20326096

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7512883A SE418247B (sv) 1975-11-17 1975-11-17 Sett att framstella kroppar med reglerad frigoring av en aktiv komponent

Country Status (24)

Country Link
US (2) US4289795A (xx)
JP (1) JPS5919526B2 (xx)
AT (1) AT354636B (xx)
AU (1) AU508266B2 (xx)
BE (1) BE848406A (xx)
CA (1) CA1075031A (xx)
CS (1) CS207374B2 (xx)
DD (1) DD128170A5 (xx)
DE (1) DE2651176A1 (xx)
DK (1) DK146213C (xx)
FI (1) FI62462C (xx)
FR (1) FR2331375A1 (xx)
GB (1) GB1560841A (xx)
HK (1) HK14683A (xx)
HU (1) HU173461B (xx)
IE (1) IE44353B1 (xx)
LU (1) LU76215A1 (xx)
MY (1) MY8400019A (xx)
NL (1) NL187259C (xx)
NO (1) NO144763C (xx)
NZ (1) NZ182621A (xx)
SE (1) SE418247B (xx)
SU (1) SU1326180A3 (xx)
ZA (1) ZA766669B (xx)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
ATE14379T1 (de) * 1981-04-27 1985-08-15 Haessle Ab Pharmazeutisches praeparat.
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
EP0094117A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
EP0094123A3 (en) * 1982-05-06 1984-07-25 THE PROCTER & GAMBLE COMPANY Therapeutic granules
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
DE3382392D1 (de) * 1982-07-09 1991-10-02 Key Pharma Dosierungsart zur dauerhaften verabreichung von chinidin.
CA1223172A (en) * 1982-09-23 1987-06-23 Sidney Melamed Encapsulated solid microbiocidal article
US5283060A (en) * 1982-09-29 1994-02-01 Shieh Tsuong R Bacillus-containing pesticide granules
IL70071A (en) * 1982-11-01 1987-12-31 Merrell Dow Pharma Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
SE458576B (sv) * 1985-06-20 1989-04-17 Lejus Medical Ab Foerfarande foer framstaellning av en guar-gum produkt
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
US5100592A (en) * 1986-03-12 1992-03-31 Washington University Technology Associated, Inc. Method and apparatus for granulation and granulated product
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
EP0294493A4 (en) * 1986-12-25 1989-07-24 Teysan Pharmaceuticals Co Ltd SLOW DISSOLUTION GRANULE AND COMPOSITE GRANULE WITH PERSISTENT EFFECT PREPARED FROM THE FIRST GRANULE.
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
HU197519B (en) * 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
DE3721721C1 (de) * 1987-07-01 1988-06-09 Hoechst Ag Verfahren zur Umhuellung von Granulaten
IT1231410B (it) * 1987-09-22 1991-12-04 Cooperativa Farmaceutica Composizione farmaceutica antiinfiammatoria ad effetto prolungato per uso topico
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US4925675A (en) * 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US4971796A (en) * 1988-10-05 1990-11-20 Sjogren Robert D Slow release pest control granule composition
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
EP0376331A3 (en) * 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Slow release drug delivery granules and process for production thereof
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE3918801A1 (de) * 1989-06-06 1991-05-08 Schmidt Walter Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung
JP2813809B2 (ja) * 1989-06-19 1998-10-22 武田薬品工業株式会社 有核顆粒製剤およびその製造法
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
US5153002A (en) * 1991-03-04 1992-10-06 University Of Montreal Biocompatible gradient controlled release implant
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
GB2267219B (en) * 1992-05-28 1996-04-03 Elan Corp Plc Differential release tablet with multiple active agents
KR100297541B1 (ko) * 1992-12-13 2001-11-26 마티에우 디올라이티 방출제어형약학적제형의제조방법및이방법에의해제조된약학적제형
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE4446468A1 (de) * 1994-12-23 1996-06-27 Basf Ag Verfahren zur Herstellung von umhüllten Tabletten
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
GB9703673D0 (en) * 1997-02-21 1997-04-09 Bradford Particle Design Ltd Method and apparatus for the formation of particles
EP1949890A3 (en) 1999-06-04 2011-05-18 ALZA Corporation Implantable gel compositions and method of manufacture
HUP0201626A3 (en) * 1999-06-04 2004-05-28 Alza Corp Mountain View Implantable gel compositions and method of manufacture
WO2001080826A2 (en) 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
GB0027357D0 (en) 2000-11-09 2000-12-27 Bradford Particle Design Plc Particle formation methods and their products
ES2663873T3 (es) * 2001-10-29 2018-04-17 Massachusetts Institute Of Technology Forma farmacéutica con perfil de liberación de orden cero fabricada por impresión tridimensional
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
GB0216562D0 (en) 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
GB0228421D0 (en) * 2002-12-05 2003-01-08 Exosect Ltd Lipid carriers
DE10260919A1 (de) * 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
AU2004237131B2 (en) 2003-05-08 2009-09-10 Nektar Therapeutics Particulate materials
GB0310636D0 (en) * 2003-05-08 2003-06-11 Nektar Therapeutics Uk Ltd Particulate materials
KR20070036019A (ko) * 2004-03-31 2007-04-02 이아이디 패리 (인디아) 리미티드 님 종자 추출물의 개선된 과립 제제 및 이것의 제조 공정
US20050244465A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Drug delivery systems and methods for treatment of an eye
US20060147517A1 (en) * 2005-01-06 2006-07-06 Cima Labs Inc. Taste masking system for non-plasticizing drugs
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928770A (en) * 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
BE623704A (xx) * 1961-10-20
US3383283A (en) * 1964-01-24 1968-05-14 Merck & Co Inc Medicinal pellets coated with overlapping porous fatty acid leaflet layers
FR1545612A (fr) * 1967-06-15 1968-11-15 Dausse Lab Procédé de fabrication de comprimés
DE1617351A1 (xx) * 1967-06-28 1972-01-05
DK123806B (da) * 1970-06-08 1972-08-07 Pharmacia As Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof.
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation

Also Published As

Publication number Publication date
SU1326180A3 (ru) 1987-07-23
AT354636B (de) 1979-01-25
JPS5919526B2 (ja) 1984-05-07
NL7612728A (nl) 1977-05-20
MY8400019A (en) 1984-12-31
GB1560841A (en) 1980-02-13
FI62462C (fi) 1983-01-10
HK14683A (en) 1983-05-13
DK146213B (da) 1983-08-01
IE44353B1 (en) 1981-11-04
ATA850576A (de) 1979-06-15
AU508266B2 (en) 1980-03-13
FR2331375A1 (fr) 1977-06-10
HU173461B (hu) 1979-05-28
AU1961776A (en) 1978-05-25
US4341759A (en) 1982-07-27
CS207374B2 (en) 1981-07-31
BE848406A (fr) 1977-05-17
NO144763B (no) 1981-07-27
DK146213C (da) 1984-01-16
DK513476A (da) 1977-05-18
DD128170A5 (de) 1977-11-02
IE44353L (en) 1977-05-17
NZ182621A (en) 1978-12-18
DE2651176A1 (de) 1977-05-18
DE2651176C2 (xx) 1987-06-11
FI763257A (xx) 1977-05-18
NL187259B (nl) 1991-03-01
ZA766669B (en) 1977-10-26
NO144763C (no) 1981-11-04
NO763807L (xx) 1977-05-20
CA1075031A (en) 1980-04-08
FI62462B (fi) 1982-09-30
LU76215A1 (xx) 1977-06-06
FR2331375B1 (xx) 1981-12-31
JPS5283921A (en) 1977-07-13
SE7512883L (sv) 1977-05-18
NL187259C (nl) 1991-08-01
US4289795A (en) 1981-09-15

Similar Documents

Publication Publication Date Title
SE418247B (sv) Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
SE420599B (sv) Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon
SE433222B (sv) Sett att framstella modifierad polysackarid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE418319B (sv) Sett att automatiskt reglera tendningsforstellningen for en motor med styrd tendning jemte anordning for genomforande av settet
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE418083B (sv) Sett att framstella halogensubstituerade pyrrolettiksyraforeningar med terapeutisk verkan
NO143350C (no) 3-oximer av d-17alfa-etynyl-19-nortestosteronestere med befruktningshindrende virkning
SE7612825L (sv) Elektrod samt sett att framstella denna
SE430344B (sv) Sett att framstella oorienterad kiselstalplat
SE410974B (sv) Filmbildande helogenhaltig fotopolymeriserbar komposition samt sett att framstella densamma
SE427006B (sv) Sett att framstella frystorkat pulver innehallande prostaglandin
SE7801687L (sv) Regleringsanordning for att forhindra lasning av fordonshjul
SE419856B (sv) Sett att framstella kroppar av alkali-beta-aluminiumoxid samt anordning for utforande av settet
SE415971B (sv) Sett att framstella substituerade bensamider med terapeutisk verkan
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE428930B (sv) Sett att framstella nya depa-stereoidestrar tillhorande ostran-serien
SE432926B (sv) Sett att framstella disubstituerade fenoletrar av 3-amino-2-hydroxipropan
SE7600769L (sv) Sett att avferga avloppsvatten
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE432092B (sv) Sett for genomforande av koronareaktioner
SE427835B (sv) Sett att framstella dipeptidderivat med terapeutisk verkan
SE426394B (sv) Sett att framstella xanten-9-karbonsyraestrar
SE7607390L (sv) Sett att avlegsna fosfat ur vattenhaltiga losningar
SE432588B (sv) Sett att framstella substituerade fenyl-alkyl-karboxylsyror

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7512883-5

Effective date: 19940610

Format of ref document f/p: F